Ignite Creation Date:
2025-12-25 @ 1:01 AM
Ignite Modification Date:
2026-06-24 @ 5:19 AM
Study NCT ID:
NCT05709093
Status:
TERMINATED
Last Update Posted:
2025-04-27
First Post:
2023-01-10
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase 3 Clinical Study to Evaluate Lemzoparlimab for Injection in Combination With Azacitidine (AZA) Versus AZA Monotherapy in Treatment-naïve Patients With Higher-risk Myelodysplastic Syndrome (MDS)
Sponsor:
TJ Biopharma Co., Ltd.
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Myelodysplastic Syndromes(MDS) | View |
Keywords: